To the Rescue

Hypoglycemia is the most common side effect of insulin treatment and can result in seizures, unconsciousness and death. Administering glucagon reverses hypoglycemia by facilitating the release of glucose into the bloodstream. Yet, according to Enject Inc., only 900,000 glucagon rescue kits are sold annually in the U.S., where there are 1.4 million Type I diabetics who should have at least one rescue product on hand.

Moreover, the two glucagon rescue products marketed in the U.S. have a total

Read the full 773 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE